The Central government, in close collaboration with the State governments and UT administrations, has
Mr. Bhalla said healthcare workers and frontline workers are being inoculated as per the priority decided by the National Expert Group on Vaccine Administration for COVID-19 (NEGVAC), and subsequently the priority groups 2 and 3 will be vaccinated.
“I would like to strongly emphasise that the National Regulatory Authority in the country has found both the vaccines safe and immunogenic. However, it has been reported that unfounded and misleading rumours are circulating on social and other media, creating doubt about the safety and efficacy of these vaccines. Such kind of rumour mongering, particularly by vested interests, can create unwarranted doubts among people at large, and there is, therefore, a need to check all such kinds of unfounded scare mongering relating to the safety and immunogenicity of the vaccines,” the letter said.
NEW DELHI : Faced with the problem of circulation of rumours about the efficacy of COVID-19 vaccines, the Centre has asked the states to check the spread
Act against anyone spreading rumours about Covid vaccines, Centre tells states
Act against anyone spreading rumours about Covid vaccines, Centre tells states
In a bid to tackle the spread of misinformation surrounding efficacy of covid-19 vaccines, Centre has requested states and UTs to take penal action against anyone involved in such activities.
advertisement
UPDATED: January 25, 2021 21:29 IST
The Centre stated that spreading rumours about the vaccines could cause unwarranted doubts among people at large ( Representative/ File)
The Government of India has requested states and UTs to check the spread of rumours about the efficacy of Covid-19 vaccines, urging them to take penal action against anyone found to be involved in the dissemination of inaccurate and ill-informed news. At present, SII s Covishield and Bharat Biotech s Covaxin are being administered to healthcare and frontline workers in India as part of the world s largest vaccination drive.
India News: The Centre has asked the states to take appropriate measures to counter the spread of unfounded and misleading rumours regarding the safety of the two
Amidst the spread of rumours around the efficacy of the Covid-19 vaccines, the Centre has asked the states to check the circulation of such false information. The Centre has also advised the states to take penal action against those who are behind the dissemination of wrong and ill-informed news.
The National Regulatory Authority in the country has found that the two vaccines Covishield, manufactured by the Serum Institute of India, and Covaxin, developed and manufactured by the Bharat Biotech Limited to be completely safe and immunogenic, emphasised Union Home Secretary Ajay Bhalla, in communication with all states and union territories.